Rishi Anand

Rishi is a neuroscientist at the Centre for Cellular and Molecular Neurobiology at the University of Oxford. His research investigates novel mechanisms of dopamine release that can be utilised as targets for the treatment of Parkinson’s disease. He has also worked on go-to-market strategy at DeepSpin and as a research scientist at Cerevance. He is excited by emerging research, particularly in the Life Sciences in Healthcare, and how these can be brought to market to improve the lives of patients.